Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper

Archive ouverte

Bacchetta, Justine | Edouard, Thomas | Laverny, Gilles | Bernardor, Julie | Bertholet-Thomas, Aurelia | Castanet, Mireille | Garnier, Charlotte | Gennero, Isabelle | Harambat, Jérôme | Lapillonne, Alexandre | Molin, Arnaud | Naud, Catherine | Salles, J.P. | Laborie, Sophie | Tounian, Patrick | Linglart, Agnès

Edité par CCSD ; Elsevier -

International audience. OBJECTIVES: Nutritional vitamin D supplements are often used in general pediatrics. Here, the aim is to address vitamin D supplementation and calcium nutritional intakes in newborns, infants, children, and adolescents to prevent vitamin D deficiency and rickets in general populations. STUDY DESIGN: We formulated clinical questions relating to the following categories: the Patient (or Population) to whom the recommendation will apply; the Intervention being considered; the Comparison (which may be "no action," placebo, or an alternative intervention); and the Outcomes affected by the intervention (PICO). These PICO elements were arranged into the questions to be addressed in the literature searches. Each PICO question then formed the basis for a statement. The population covered consisted of children aged between 0 and 18 years and premature babies hospitalized in neonatology. Two groups were assembled: a core working group and a voting panel from different scientific pediatric committees from the French Society of Pediatrics and national scientific societies. RESULTS: We present here 35 clinical practice points (CPPs) for the use of native vitamin D therapy (ergocalciferol, vitamin D(2) and cholecalciferol, vitamin D(3)) and calcium nutritional intakes in general pediatric populations. CONCLUSION: This consensus document was developed to provide guidance to health care professionals on the use of nutritional vitamin D and dietary modalities to achieve the recommended calcium intakes in general pediatric populations. These CPPs will be revised periodically. Research recommendations to study key vitamin D outcome measures in children are also suggested.

Suggestions

Du même auteur

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience

Archive ouverte | Bernardor, Julie | CCSD

International audience. Background Cinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk o...

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience

Archive ouverte | Bernardor, Julie | CCSD

International audience. Background Cinacalcet is a calcimimetic approved in adults with primary hyperparathyroidism (PHPT). Few cases reports described its use in pediatric HPT, with challenges related to the risk o...

Genotype-phenotype Description of Vitamin D–dependent Rickets 1A: CYP27B1 p.(Ala129Thr) Variant Induces a Milder Disease

Archive ouverte | Méaux, Marie-Noëlle | CCSD

International audience. Abstract Introduction Vitamin D–dependent rickets type 1A (VDDR1A) is a rare genetic disease associated with loss-of-function variations in the gene encoding the vitamin D–activating enzyme 1...

Chargement des enrichissements...